Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03744767
What this trial is testing

Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr Irmela MANTEL 20
Not applicableStudy completedNCT03679156
What this trial is testing

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor

Who this might be right for
Neovascular Age-related Macular Degeneration
Hospital Hietzing 18
Early research (Phase 1)UnknownNCT03675880
What this trial is testing

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

Who this might be right for
AMD
Lee's Pharmaceutical Limited 24
Not applicableUnknownNCT00640640
What this trial is testing

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Sheba Medical Center 60
Early research (Phase 1)Study completedNCT03630315
What this trial is testing

CLN-0046: Treatment of AMD Subjects With OTX-TKI

Who this might be right for
Neovascular Age-related Macular Degeneration
Ocular Therapeutix, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT03066258
What this trial is testing

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Who this might be right for
Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
REGENXBIO Inc. 42
Early research (Phase 1)Looking for participantsNCT05803785
What this trial is testing

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Benobio Co., Ltd. 18
Not applicableStudy completedNCT01306591
What this trial is testing

Bevacizumab for Neovascular Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Peking University People's Hospital 210
Not applicableEnded earlyNCT00902785
What this trial is testing

Early Markers Of Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization (CNV)Age-related Macular Degeneration (AMD)Early Markers
Pfizer 100
Early research (Phase 1)Study completedNCT01033721
What this trial is testing

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Paloma Pharmaceuticals, Inc. 13
Post-approval studies (Phase 4)UnknownNCT00813891
What this trial is testing

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationVisual Acuity
McGill University Health Centre/Research Institute of the McGill University Health Centre 180
Testing effectiveness (Phase 2)Study completedNCT03927690
What this trial is testing

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 91
Post-approval studies (Phase 4)Study completedNCT02441816
What this trial is testing

VITAL - Individualising Therapy for Neovascular AMD With Aflibercept

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 50
Not applicableStudy completedNCT07105228
What this trial is testing

Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

Who this might be right for
Retinal Vasculitis
Regeneron Pharmaceuticals 290,000
Early research (Phase 1)Study completedNCT04422899
What this trial is testing

Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
AiViva BioPharma, Inc. 3
Testing effectiveness (Phase 2)UnknownNCT06183814
What this trial is testing

EXG102-031 in Participants With wAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Not applicableStudy completedNCT01291121
What this trial is testing

Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Who this might be right for
Neovascular Age-related Macular Degeneration
Yonsei University 30
Not applicableStudy completedNCT07744984
What this trial is testing

The Efficacy of Home OCT Supported Management in Patients Diagnosed With Neovascular-AMD and Undergoing a Drug Switch to Faricimab

Who this might be right for
Age-Related Macular Degeneration (AMD)Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Rabin Medical Center 12
Early research (Phase 1)WithdrawnNCT02450981
What this trial is testing

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Biocad
Not applicableLooking for participantsNCT04985487
What this trial is testing

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation